Journal of Clinical and Translational Hepatology

Papers
(The TQCC of Journal of Clinical and Translational Hepatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies271
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease185
Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options46
Liver Transplantation Beyond Milan Criteria45
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver44
NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States35
Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review30
Incidence, Mortality and Predictors of Acute Kidney Injury in Patients with Cirrhosis: A Systematic Review and Meta-analysis30
Macrophage Phenotypes and Hepatitis B Virus Infection29
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease29
Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases28
What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective27
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study26
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD23
Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?20
Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications20
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak19
Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study19
Antihepatic Fibrosis Drugs in Clinical Trials18
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications16
Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise16
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy16
Management of Hepatorenal Syndrome: A Review16
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review16
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome15
Cytokine Storm of COVID-19 and its Impact on Patients with and without Chronic Liver Disease15
Statin-induced Liver Injury Patterns: A Clinical Review15
Guidelines for Prevention and Treatment of Chronic Hepatitis B14
Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review14
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease13
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma13
COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery13
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail12
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis12
Prevention of HBV Recurrence after Liver Transplant: A Review11
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update11
Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts11
A 3D Human Liver Model of Nonalcoholic Steatohepatitis10
Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review10
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome10
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence10
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease10
Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis10
HEV and HBV Dual Infection: A Review9
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice9
Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis9
Guidelines for the Management of Cholestatic Liver Diseases (2021)9
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment9
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease9
Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway9
Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents9
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists9
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma8
Body Building and Aminotransferase Elevations: A Review8
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review8
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally8
Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B8
Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City8
Infections in Alcoholic Hepatitis8
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates8
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges8
Selective Androgen Receptor Modulators: An Emerging Liver Toxin7
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 20197
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling7
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update7
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver7
Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases7
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease7
A Nomogram-based Model to Predict Neoplastic Risk for Patients with Gallbladder Polyps7
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)7
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis7
Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment7
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation7
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science7
Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China7
Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?7
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review6
Hepatic Histoplasmosis: An Update6
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies6
Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease6
Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?6
A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01)6
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma6
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)6
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy6
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis6
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A Cohort Study6
Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease6
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection6
Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice6
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure6
Clinical Considerations of Coagulopathy in Acute Liver Failure6
Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review6
Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure5
A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma5
Targeted Mitochondrial Delivery to Hepatocytes: A Review5
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination5
2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus5
Erythroid Lineage Cells in the Liver: Novel Immune Regulators and Beyond5
Hepatotoxicity Induced by Biological Agents: Clinical Features and Current Controversies5
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection5
Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning5
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection5
Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition5
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice5
Expression and Regulatory Network Analysis of Function of Small Nucleolar RNA Host Gene 4 in Hepatocellular Carcinoma5
Approaches to Assessing Burden in Caregivers of Patients with Cirrhosis5
Detection of Prognostic Biomarkers for Hepatocellular Carcinoma through CircRNA-associated CeRNA Analysis5
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China5
Update on Sphincter of Oddi Dysfunction: A Review5
Coronavirus Disease-2019 (COVID-19) and the Liver5
Racial and Health Disparities among Cirrhosis-related Hospitalizations in the USA5
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis5
CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop5
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis5
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver5
Sarcopenia in Chronic Liver Disease: A Metabolic Perspective5
Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time5
Elastography for Longitudinal Assessment of Liver Fibrosis after Antiviral Therapy: A Review5
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma5
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China5
HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site5
Hispanic Patients with Primary Biliary Cholangitis Have Decreased Access to Care Compared to Non-Hispanics5
Nonalcoholic Fatty Liver Disease after Liver Transplant4
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment4
Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo4
Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver Failure4
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence4
HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?4
Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis4
Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study4
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation4
Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype4
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India4
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis4
MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life4
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)4
Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis4
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma4
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions4
Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis4
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease4
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome4
UMSCs Attenuate LPS/D-GalN-Induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway4
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase4
Complementary and Alternative Medicine-related Drug-induced Liver Injury in Iran4
Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection4
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center4
Impact of Liver Injury in COVID-19 Patients: Single-center Retrospective Cohort Analysis4
Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy4
0.025269985198975